Brain hemorrhage treatment

Reading File

Searching the Web

brain hemorrhage treatment guidelines 2024 2025

Searching PubMed

"intracranial hemorrhage" AND treatment

Finding Sources

Searching PubMed

"intracerebral hemorrhage" AND "surgical treatment" AND "minimally invasive"

Finding Sources

Reading File

Loading Image

Here is a thorough, textbook-grounded overview of brain hemorrhage treatment, organized by hemorrhage type.

Brain Hemorrhage Treatment

Brain (intracranial) hemorrhage falls into several categories - intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and traumatic forms (epidural/subdural hematoma). Together they account for about 20% of all strokes worldwide. Treatment priorities differ by type but share common emergency principles.

CT Imaging - The First Step

Non-contrast CT is the initial imaging of choice. Blood appears hyperdense (bright white). The appearance below shows a large right-sided parietal intraparenchymal hemorrhage:

Large right-sided parietal intraparenchymal hemorrhage on CT

CT establishes volume, location, extension into the ventricles, and mass effect - all of which guide treatment decisions. - Tintinalli's Emergency Medicine, p. 1159

I. Spontaneous Intracerebral Hemorrhage (ICH)

ICH accounts for ~75% of hemorrhagic strokes. It carries a 30-day mortality of ~50% and a 7-day mortality of ~30%. Only 1 in 5 survivors is functionally independent at 1 year. - Tintinalli's Emergency Medicine, p. 1158

A. Immediate General Measures

All patients should be managed in a monitored critical care setting. Core priorities:

Measure	Detail
Airway	Secure airway; intubation + neuromuscular blockade if needed for ICP
Head position	Elevate head of bed 30 degrees to reduce ICP
Temperature	Reduce hyperthermia aggressively with antipyretics; target ≤37.5°C
Glucose	Maintain 120-180 mg/dL (avoid hypo- or hyperglycemia >160 mg/dL)
Seizures	Treat if they occur; prophylactic anticonvulsants only in coma + intracranial hypertension (fosphenytoin/phenytoin 15-20 mg/kg IV load)
Corticosteroids	Contraindicated - do NOT give steroids for ICP in ICH

Tintinalli's Emergency Medicine, p. 1159; Goldman-Cecil Medicine, p. 3531

B. Blood Pressure Management

BP is typically elevated acutely due to a generalized sympathoadrenal response. Current AHA/ASA 2025 guidelines (also reflected in ESO 2025):

SBP	Recommended Action
>220 mm Hg	Aggressive reduction with continuous IV infusion
150-220 mm Hg	Acute lowering to SBP <140 mm Hg is safe and may improve functional outcome
SBP reduction	Should NOT exceed 70 mm Hg from baseline (risk of cerebral hypoperfusion)
SBP <120 mm Hg	Potentially harmful - ATACH-2 trial showed no benefit and possible harm

Preferred IV agents: labetalol, esmolol (beta-blockers). Calcium channel blockers (e.g., nifedipine) are used less often because they can raise intracranial pressure, potentially worsening cerebral perfusion pressure. - Adams and Victor's Principles of Neurology, p. 847-848; Tintinalli's, p. 1159

C. Intracranial Pressure (ICP) Management

For large hemorrhages causing mass effect or coma:

Controlled hyperventilation to PaCO₂ of 25-30 mm Hg (short-term bridge)
Osmotic diuretics (mannitol) to dehydrate brain tissue
IV fluids: normal saline only (avoid hypotonic fluids)
Hypertonic saline as an alternative osmotic agent
Invasive ICP monitoring is generally indicated when aggressive ICP reduction measures are used
Maintain cerebral perfusion pressure (CPP) >60-70 mm Hg
Adams and Victor's Principles of Neurology, p. 847

D. Reversal of Anticoagulation

Anticoagulant-associated ICH has worse outcomes. Reversal should be done urgently regardless of INR value:

Anticoagulant	Reversal Agent
Warfarin (VKA)	Vitamin K 5-10 mg IV (full effect 12-24 h) + 4-factor PCC (preferred) or FFP
Heparin	Protamine ~1 mg per 100 units of heparin (dose adjusted by time since last dose)
Direct Xa inhibitors (rivaroxaban, apixaban)	Andexanet alfa (ESO 2025 recommendation)
Dabigatran	Idarucizumab
Recombinant factor VIIa	No longer recommended outside clinical trials
Antiplatelet-associated ICH	Platelet transfusion not routinely recommended (ESO 2025 downgraded this)

Fresh frozen plasma (FFP) contains variable clotting factors and requires large volume (15 mL/kg); 4-factor PCC is now preferred for VKA reversal for speed and reliability. - Tintinalli's Emergency Medicine, p. 1159-1160; ESO/EANS 2025 Guidelines

E. Surgical Treatment

Surgery remains controversial for supratentorial ICH. However, cerebellar hemorrhage is a surgical emergency:

Cerebellar ICH >15 mL - surgical evacuation recommended (ESO 2025)
Supratentorial ICH (30-100 mL) - decompressive surgery showed fewer patients with severe disability (mRS 5-6) at 180 days in recent trials (ESO 2025)
Minimally invasive surgery (MIS) - increasingly favored where technically available
Intraventricular hemorrhage (IVH) - external ventricular drainage (EVD) + intraventricular thrombolysis improves outcomes
Hydrocephalus - EVD placement

Classic open craniotomy for deep supratentorial ICH has generally not shown consistent survival benefit in large trials, but patient selection and evolving MIS techniques are changing this landscape. - Adams and Victor's, p. 848; ESO/EANS 2025

ICH Severity Score

The ICH Score (Hemphill) predicts 30-day mortality:

Component	Points
GCS 3-4	2
GCS 5-12	1
GCS 13-15	0
ICH volume ≥30 cm³	1
Intraventricular extension	1
Infratentorial location	1
Age ≥80 years	1

30-day mortality: 0% (score 0), 13% (1), 26% (2), 72% (3), 97% (4), 100% (score ≥5) - Goldman-Cecil Medicine, p. 3547

II. Subarachnoid Hemorrhage (SAH)

SAH accounts for ~25% of hemorrhagic strokes. The most common non-traumatic cause is rupture of a saccular (berry) aneurysm at circle of Willis bifurcations. The classic presentation is a sudden, severe "thunderclap" headache, often with nausea, vomiting, loss of consciousness, and nuchal rigidity. - Goldman-Cecil Medicine, p. 3141-3158

Treatment Goals

Limit initial brain injury
Prevent rebleeding (most urgent in the first 24-72 hours)
Prevent and treat vasospasm

A. Definitive Treatment of Ruptured Aneurysm

Approach	Details
Endovascular coiling	Preferred for most aneurysms; catheter-based platinum coil packing
Surgical clipping	Open craniotomy with metal clip across aneurysm neck; preferred for certain anatomical locations

The choice between clipping and coiling depends on aneurysm shape, location, neck geometry, and patient factors.

B. Vasospasm Prevention and Treatment

Nimodipine (oral, 60 mg every 4 hours for 21 days) - standard of care; reduces morbidity from vasospasm
Induced hypertension ("triple H therapy" - hypertension, hypervolemia, hemodilution) - used for symptomatic vasospasm, though evidence for hypervolemia alone is mixed
Endovascular angioplasty or intra-arterial papaverine for refractory vasospasm

C. Hydrocephalus

Occurs in ~40% of cases from blood obstructing CSF outflow. Treated with EVD placement.

III. Traumatic Hemorrhage (Epidural/Subdural)

Type	Mechanism	Treatment
Epidural hematoma	Arterial (middle meningeal artery tear); lens-shaped on CT	Emergency surgical evacuation if neurological deterioration or volume >30 mL
Acute subdural hematoma	Bridging vein tear; crescent-shaped; often elderly/anticoagulated	Surgical evacuation if >10 mm thick or midline shift >5 mm
Chronic subdural	Gradual accumulation; may be managed with burr holes or observation

IV. General ICU/Secondary Prevention Measures

Multidisciplinary rehabilitation after the acute phase improves functional outcomes
Strict long-term BP control is the most important measure to prevent recurrent ICH
Antiplatelet therapy can be safely restarted at ~2-3 months post-bleed
Anticoagulants: restart timing individualized; most clinicians wait at least 10 days
Survivors of ICH have a 3x higher risk of subsequent ischemic stroke and 2x higher risk of MI - cardiovascular prevention is essential
Prophylactic anticonvulsants are not needed unless a seizure has occurred (seizure risk after ICH is lower than after ischemic stroke)
Goldman-Cecil Medicine, p. 3553-3555; Adams and Victor's Principles of Neurology, p. 835-848

Key References

Adams and Victor's Principles of Neurology, 12th Ed., Chapter 33
Goldman-Cecil Medicine, 26th Ed., Chapter 377
Tintinalli's Emergency Medicine, Chapter 166
Frameworks for Internal Medicine, Chapter 43
AHA/ASA 2022 ICH Guideline (PMID: 35579034) - with 2025 updates
ESO/EANS 2025 ICH Guideline

This is a shared conversation. Sign in to Orris to start your own chat.